Browse by author
Lookup NU author(s): Professor David KavanaghORCiD,
Professor Tim Goodship,
Dr Anna Richards
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
The haemolytic uraemic syndrome (HUS) is characterized by the triad of thrombocytopenia, microangiopathic haemolytic anaemia and acute renal failure. HUS may be classified as either diarrhoeal-associated or non-diarrhoeal/atypical (aHUS). aHUS has recently been shown to be a disease of complement dysregulation, with 50% of cases involving the complement regulatory genes, factor H (CFH), membrane cofactor protein (MCP; CD46), and factor I (IF). However, incomplete penetrance of mutations in each of these genes is reported. This suggests that a precipitating event or trigger is required to unmask the complement regulatory deficiency. The reported precipitating events predominantly cause endothelial injury. Discovery of these mutations has revealed important genotype-phenotype correlations. MCP-HUS has a better prognosis and a better outcome after transplantation than either CFH-HUS or IF-HUS. © The Author 2006.
Author(s): Kavanagh D, Goodship THJ, Richards A
Publication type: Review
Publication status: Published
Journal: British Medical Bulletin
ISSN (print): 0007-1420
ISSN (electronic): 1471-8391
PubMed id: 16968692